Abstract
[This corrects the article DOI: 10.1371/journal.pone.0198389.].
Highlights
Correction: A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer
There is an error in the maximum plasma concentration of niclosamide reported in the “Results” section of the Abstract
The correct concentration range is: 35.7 to 182 ng/mL
Read more 
Summary
Introduction
There is an error in the maximum plasma concentration of niclosamide reported in the “Results” section of the Abstract.
Results
Conclusion
Sign-in/Register to view highlights & summary Full Text Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
